Quantitative Systematic Strategies LLC Axonics, Inc. Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 06, 2021	SELL	$49.14 - $59.89 $198,722 - $242,195	-4,044 Reduced 39.61%	6,166 $369,000
Q4 2020 Feb 09, 2021	SELL	$42.19 - $51.5 $91,046 - $111,137	-2,158 Reduced 17.45%	10,210 $510,000
Q3 2020 Nov 09, 2020	SELL	$35.33 - $51.04 $321,503 - $464,464	-9,100 Reduced 42.39%	12,368 $631,000
Q2 2020 Aug 04, 2020	BUY	$22.91 - $39.83 $491,831 - $855,070	21,468 New	21,468 $754,000
Q1 2019 Apr 15, 2019	SELL	$13.32 - $24.35 $144,042 - $263,320	-10,814 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$13.2 - $16.43 $142,744 - $177,674	10,814 New	10,814 $163,000

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.